{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,5,30]],"date-time":"2024-05-30T00:29:02Z","timestamp":1717028942913},"reference-count":18,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,5,29]]},"DOI":"10.7759\/cureus.61322","type":"journal-article","created":{"date-parts":[[2024,5,29]],"date-time":"2024-05-29T19:56:39Z","timestamp":1717012599000},"source":"Crossref","is-referenced-by-count":0,"title":["Toxic Thyroid Adenoma Presenting as Apathetic Hyperthyroidism: A Case Report"],"prefix":"10.7759","author":[{"given":"Mina","family":"Hanna","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bo","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ravindraprasad","family":"Shekarappa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/B978-0-12-801238-3.96022-7","article-title":"Thyroid gland: anatomy and physiology","author":"Benvenga S","year":"2018","unstructured":"Benvenga S, Tuccari G, Ieni A, Vita R. Thyroid gland: anatomy and physiology. Encyclopedia of Endocrine Diseases (Second Edition). Elsevier Inc., Amsterdam, Netherlands; 2018. 4:382-90. 10.1016\/B978-0-12-801238-3.96022-7"},{"key":"ref2","article-title":"Physiology, Thyroid Function","author":"Armstrong M","year":"2023","unstructured":"Armstrong M, Asuka E, Fingeret A. Physiology, Thyroid Function. StatPearls [Internet], Treasure Island (FL); 2023."},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.21037\/gs.2019.11.01","article-title":"Hyperthyroidism","volume":"9","author":"Doubleday AR","year":"2020","unstructured":"Doubleday AR, Sippel RS. Hyperthyroidism. Gland Surg. 2020, 9:124-35. 10.21037\/gs.2019.11.01","journal-title":"Gland Surg"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-319-45013-1_18","article-title":"Toxic adenoma and multinodular toxic goiter","author":"Tonacchera M","year":"2018","unstructured":"Tonacchera M, F\u00fchrer D. Toxic adenoma and multinodular toxic goiter. Thyroid Diseases. Endocrinology. Springer, Cham, Switzerland; 2018. 10.1007\/978-3-319-45013-1_18"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1210\/jcem.78.5.8175954","article-title":"Thyroid hormone and the cardiovascular system: from theory to practice","volume":"78","author":"Klein I","year":"1994","unstructured":"Klein I, Ojamaa K. Thyroid hormone and the cardiovascular system: from theory to practice. J Clin Endocrinol Metab. 1994, 78:1026-7. 10.1210\/jcem.78.5.8175954","journal-title":"J Clin Endocrinol Metab"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/0190-9622(92)70130-8","article-title":"Cutaneous manifestations of thyroid disease","volume":"26","author":"Heymann WR","year":"1992","unstructured":"Heymann WR. Cutaneous manifestations of thyroid disease. J Am Acad Dermatol. 1992, 26:885-902. 10.1016\/0190-9622(92)70130-8","journal-title":"J Am Acad Dermatol"},{"key":"ref7","article-title":"Thyroid Adenoma","author":"Mulita F","year":"2022","unstructured":"Mulita F, Anjum F. Thyroid Adenoma. StatPearls [Internet], Treasure Island (FL); 2022."},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1308\/rcsann.2021.0008","article-title":"Toxic adenoma: to biopsy or not to biopsy?","volume":"103","author":"Goonoo MS","year":"2021","unstructured":"Goonoo MS, Arshad MF, Tahir F, Balasubramanian SP. Toxic adenoma: to biopsy or not to biopsy?. Ann R Coll Surg Engl. 2021, 103:e319-23. 10.1308\/rcsann.2021.0008","journal-title":"Ann R Coll Surg Engl"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1089\/thy.2015.0178","article-title":"A clinical framework to facilitate risk stratification when considering an active surveillance alternative to immediate biopsy and surgery in papillary microcarcinoma","volume":"26","author":"Brito JP","year":"2016","unstructured":"Brito JP, Ito Y, Miyauchi A, Tuttle RM. A clinical framework to facilitate risk stratification when considering an active surveillance alternative to immediate biopsy and surgery in papillary microcarcinoma. Thyroid. 2016, 26:144-9. 10.1089\/thy.2015.0178","journal-title":"Thyroid"},{"key":"ref10","unstructured":"U.S. Cancer Statistics Working Group. U.S. cancer statistics data visualizations tool, based on 2021 submission data. (2022). Accessed. January 12 2023: https:\/\/www.cdc.gov\/cancer\/dataviz."},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1210\/jcem.82.1.3691","article-title":"Two autonomous nodules of a patient with multinodular goiter harbor different activating mutations of the thyrotropin receptor gene","volume":"82","author":"Duprez L","year":"1997","unstructured":"Duprez L, Hermans J, Van Sande J, Dumont JE, Vassart G, Parma J. Two autonomous nodules of a patient with multinodular goiter harbor different activating mutations of the thyrotropin receptor gene. J Clin Endocrinol Metab. 1997, 82:306-8. 10.1210\/jcem.82.1.3691","journal-title":"J Clin Endocrinol Metab"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.3390\/nu4111740","article-title":"History of U.S. iodine fortification and supplementation","volume":"4","author":"Leung AM","year":"2012","unstructured":"Leung AM, Braverman LE, Pearce EN. History of U.S. iodine fortification and supplementation. Nutrients. 2012, 4:1740-6. 10.3390\/nu4111740","journal-title":"Nutrients"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1152\/physrev.1992.72.3.667","article-title":"Physiological and pathological regulation of thyroid cell proliferation and differentiation by thyrotropin and other factors","volume":"72","author":"Dumont JE","year":"1992","unstructured":"Dumont JE, Lamy F, Roger P, Maenhaut C. Physiological and pathological regulation of thyroid cell proliferation and differentiation by thyrotropin and other factors. Physiol Rev. 1992, 72:667-97. 10.1152\/physrev.1992.72.3.667","journal-title":"Physiol Rev"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1210\/mend.9.6.8592518","article-title":"Somatic mutations causing constitutive activity of the thyrotropin receptor are the major cause of hyperfunctioning thyroid adenomas: identification of additional mutations activating both the cyclic adenosine 3',5'-monophosphate and inositol phosphate-Ca2+ cascades","volume":"9","author":"Parma J","year":"1995","unstructured":"Parma J, Van Sande J, Swillens S, Tonacchera M, Dumont J, Vassart G. Somatic mutations causing constitutive activity of the thyrotropin receptor are the major cause of hyperfunctioning thyroid adenomas: identification of additional mutations activating both the cyclic adenosine 3',5'-monophosphate and inositol phosphate-Ca2+ cascades. Mol Endocrinol. 1995, 9:725-33. 10.1210\/mend.9.6.8592518","journal-title":"Mol Endocrinol"},{"key":"ref15","doi-asserted-by":"crossref","DOI":"10.1001\/jama.1995.03520340064038","article-title":"Treatment guidelines for patients with hyperthyroidism and hypothyroidism. Standards of Care Committee, American Thyroid Association","volume":"273","author":"Singer PA","year":"1995","unstructured":"Singer PA, Cooper DS, Levy EG, et al.. Treatment guidelines for patients with hyperthyroidism and hypothyroidism. Standards of Care Committee, American Thyroid Association. JAMA. 1995, 273:808-12.","journal-title":"JAMA"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(92)90681-z","article-title":"Beta-adrenergic blockade for the treatment of hyperthyroidism","volume":"93","author":"Geffner DL","year":"1992","unstructured":"Geffner DL, Hershman JM. Beta-adrenergic blockade for the treatment of hyperthyroidism. Am J Med. 1992, 93:61-8. 10.1016\/0002-9343(92)90681-z","journal-title":"Am J Med"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1089\/thy.2016.0229","article-title":"2016 American Thyroid Association guidelines for diagnosis and management of hyperthyroidism and other causes of thyrotoxicosis","volume":"26","author":"Ross DS","year":"2016","unstructured":"Ross DS, Burch HB, Cooper DS, et al.. 2016 American Thyroid Association guidelines for diagnosis and management of hyperthyroidism and other causes of thyrotoxicosis. Thyroid. 2016, 26:1343-421. 10.1089\/thy.2016.0229","journal-title":"Thyroid"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1530\/acta.0.0840576","article-title":"Glucose tolerance and insulin secretion in hyperthyroidism","volume":"84","author":"Andersen OO","year":"1977","unstructured":"Andersen OO, Friis T, Ottesen B. Glucose tolerance and insulin secretion in hyperthyroidism. Acta Endocrinol (Copenh). 1977, 84:576-87. 10.1530\/acta.0.0840576","journal-title":"Acta Endocrinol (Copenh)"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/177817-toxic-thyroid-adenoma-presenting-as-apathetic-hyperthyroidism-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,29]],"date-time":"2024-05-29T19:56:43Z","timestamp":1717012603000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/177817-toxic-thyroid-adenoma-presenting-as-apathetic-hyperthyroidism-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,29]]},"references-count":18,"URL":"https:\/\/doi.org\/10.7759\/cureus.61322","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5,29]]}}}